Hologic, Inc. is a developer, manufacturer, and supplier of diagnostic products, medical imaging systems, and surgical products. The Company’s core business units focus on diagnostics, breast health, gynecological surgical, and skeletal health. Its major products include the Selenia Dimension mammography system, the Discovery and Horizon bone densitometers, the NovaSure endometrial ablation device, the ThinPrep pap test, and the Aptima, Cervista, and Prodesse diagnostic assays.

Company Growth (employees)
Type
Public
HQ
Marlborough, US
Founded
1985
Size (employees)
5,333 (est)
Hologic was founded in 1985 and is headquartered in Marlborough, US

Key People at Hologic

Stephen P. MacMillan

Stephen P. MacMillan

President & CEO
Robert W. McMahon

Robert W. McMahon

CFO
Eric B. Compton

Eric B. Compton

COO

Hologic Office Locations

Hologic has an office in Marlborough
Marlborough, US (HQ)
250 Campus Dr

Hologic Data and Metrics

Hologic Financial Metrics

Hologic's revenue was reported to be $715.4 m in Q2, 2017
USD

Revenue (Q2, 2017)

715.4 m

Net income (Q2, 2017)

613.3 m

EBIT (Q2, 2017)

999.8 m

Market capitalization (21-Sep-2017)

10.8 b

Cash (01-Apr-2017)

1.1 b
Hologic's current market capitalization is $10.8 b.
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.8 b2 b2.5 b2.5 b2.7 b2.8 b

Revenue growth, %

12%24%2%7%5%

Cost of goods sold

818.2 m731.3 m755.5 m756.8 m

Gross profit

1.7 b1.8 b1.9 b2.1 b
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

632.6 m652.8 m655.5 m693.9 m695.2 m693.3 m717.4 m734.4 m715.4 m

R&D expense

52.5 m52 m53.3 m56 m51.7 m59.1 m58.8 m54.4 m55.4 m

General and administrative expense

64.7 m61.3 m60.3 m73.1 m77 m62.4 m62.5 m69.8 m117.4 m

Operating expense total

117.2 m113.3 m113.6 m129.1 m128.7 m121.5 m121.3 m124.2 m172.8 m
USDY, 2010Y, 2011Y, 2012Y, 2013FY, 2014FY, 2015FY, 2016

Cash

515.6 m712.3 m560.4 m822.5 m736.1 m491.3 m548.4 m

Accounts Receivable

325.3 m

Inventories

289.4 m330.6 m283.1 m274.7 m

Current Assets

1.6 b1.6 b1.3 b1.3 b
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

632.5 m544 m670.5 m885 m650.3 m316.3 m441.5 m646 m1.1 b

Inventories

329.8 m310.3 m298.2 m295 m286.4 m285.1 m280.5 m258.3 m384 m

Current Assets

1.4 b1.3 b1.4 b1.6 b1.4 b1.1 b1.2 b2.3 b2.1 b

PP&E

467.4 m458.2 m451 m449.9 m454.5 m454.1 m451.5 m432.6 m482.7 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(1.2 b)17.3 m131.6 m330.8 m

Depreciation and Amortization

95.5 m94.7 m81.5 m293.4 m

Accounts Receivable

4.1 m7.9 m(30 m)(31.8 m)

Inventories

25.2 m(45 m)43.9 m7.6 m
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(10.8 m)29.2 m77 m106.5 m84.9 m153.8 m238.7 m86.5 m613.3 m

Depreciation and Amortization

72.7 m20.3 m40.7 m60.8 m19.9 m40.2 m61.3 m20.4 m39.5 m

Accounts Receivable

28.4 m(9.7 m)3.3 m3.5 m4.3 m(7 m)(10.8 m)21.5 m28 m

Inventories

(42.2 m)18.7 m29 m32.9 m(3.6 m)(2.3 m)2.1 m(20.7 m)(29 m)
Y, 2017

Financial Leverage

3.1 x
Show all financial metrics

Hologic Market Value History

Hologic Median Salaries

Source: 31 public H-1B filings from Hologic

Traffic Overview of Hologic

Hologic Online and Social Media Presence

Hologic News and Updates

Hologic wins emergency U.S. authorization for Zika test

June 17 (Reuters) - Hologic Inc won emergency U.S. authorization to sell its Zika test, expanding the number of public and private labs that can test for the virus as health officials brace for a rise this summer in the number of infections.

BRIEF-FDA grants emergency use authorization for Hologic's Aptima zika virus assay

* FDA grants emergency use authorization for Hologic's Aptima zika virus assay

Hologic Company Life and Culture

You may also be interested in